drugset
Drugs / DaZhu Rhodiola Rosea Capsule
last change Feb 2019 re-read 3 minutes ago

DaZhu Rhodiola Rosea Capsule

Traditional medicine (herbal / TCM)

Developed for
coronary artery disorder
Investigated by
Beijing Anzhen Hospital · Jiangsu Kangyuan Pharmaceutical Co. Ltd

Trials 1

today NCT03633890 · Ph 4
20192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT03633890 Aug 2018 → Feb 2019 coronary artery disorder Beijing Anzhen Hospital Unknown No outcome recorded

Evidence & citations 3 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as DaZhu Rhodiola Rosea Capsule ClinicalTrials.gov intervention name — accepted as the source's own label NCT03633890 ↗
Modality Traditional medicine (herbal / TCM) “traditional Chinese medicine DaZhu Rhodiola Rosea Capsule” NCT03633890 ↗
Route Oral “Oral administration, 4 capsules, 3 times a day, for 8 weeks” NCT03633890 ↗